Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gerald Doyle
Erratum To: Cilengitide (EMD 121974, NSC 707544) in Asymptomatic Metastatic Castration Resistant Prostate Cancer Patients: A Randomized Phase II Trial by the Prostate Cancer Clinical Trials Consortium
Investigational New Drugs
Oncology
Pharmacology
Related publications
Phase 1 Trial of High-Dose Exogenous Testosterone in Patients With Castration-Resistant Metastatic Prostate Cancer
European Urology
Urology
Phase II Trial of Cisplatin Plus Prednisone in Docetaxel-Refractory Castration-Resistant Prostate Cancer Patients
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase II Trial of Prostate-Specific Membrane Antigen Antibody Drug Conjugate (PSMA ADC) in Taxane-Refractory Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Patient Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase I Trial With a Combination of Docetaxel and 153Sm-Lexidronam in Patients With Castration-Resistant Metastatic Prostate Cancer
Urologic Oncology: Seminars and Original Investigations
Oncology
Urology
End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Concepts for Cabazitaxel in the Management of Metastatic Castration‐resistant Prostate Cancer
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
Clinical Medicine Insights: Oncology
Oncology
